Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as...

Related Keywords

Boston ,Massachusetts ,United States ,Amanda Cray ,Fusion Pharmaceuticals Inc ,Niowave Inc ,Company Board Of Directors ,Nasdaq ,Astrazeneca ,Fusion Pharmaceuticals ,Prnewswire Fusion Pharmaceuticals Inc ,Investor Relations Corporate Communications ,Nasdaq Listing Rule ,Repair Inhibitors ,Senior Director ,Investor Relations ,Corporate Communications ,